2024 Pharmaceutical Value chain 
Frost & Sullivan Manufacturing
DECEMBER 25, 2024
Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Low-value drugs with significant product homogeneity face a higher risk of market elimination.
Robotics Business Review
JANUARY 26, 2024
“By teaming with Mujin, a leader in robotics technology, Accenture will be able to help our clients take advantage of AI and robotics to connect data throughout the manufacturing and logistics value chain, further contributing to the data-driven transformation of Japan’s important manufacturing and logistics industries.” .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frost & Sullivan Manufacturing
OCTOBER 9, 2024
San Antonio, TX — October 9, 2024 — Frost & Sullivan recently researched the intelligent automation industry and, based on its findings, recognizes Bosch with the Technology Innovation Leadership Award. This platform also allows Bosch to offer flexible and comprehensive solutions customized to unique client specifications.
Dinesh Mishra
DECEMBER 29, 2024
Generative AI: From Experimentation to Execution : 2024 has seen the early stages of AI and Generative AI experimentation, but 2025 will mark a transition to scaled implementations. Strategic investments in AI and technology integration will empower companies to remain adaptable.
Frost & Sullivan Manufacturing
AUGUST 29, 2024
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. increase from 2022. However, the pharma/biopharma industry overall shows stagnant R&D activity. Total R&D expenditure is approximately $276.81
Additive Manufacturing
JANUARY 5, 2023
Value Chain: Sigma Additive Solutions and Dyndrite Announce Agreement to Build Connected In-process Data Software Using Dyndrite Application Development Kit : Sigma Additive Solutions , Inc. Triastek and Siemens Announce Strategic Collaboration to Accelerate Digital Transformation of the Pharmaceutical Industry : Triastek, Inc.
Frost & Sullivan Manufacturing
FEBRUARY 6, 2023
Agile Partnership Models for Drug Discovery and Pre-clinical Drug Testing Services – CROs such as Syngene International, Aragen Life Sciences, Veeda Clinical Research, Aurigene Pharmaceutical Services, etc., million investment in R&D in 2023, the Indian pharmaceutical industry is set to witness growth in 2023.
Expert insights. Personalized for you.
52 
Let's personalize your content